Association between 25‐OH vitamin D and insulin is independent of lipoatrophy in HIV

Objective  Vitamin D deficiency (VDD) is prevalent in HIV, and following antiretroviral therapy (ART), increased rates of lipoatrophy and metabolic abnormalities are described. We investigated the relationships between 25‐hydroxyvitamin D [25(OH)D] and other metabolic parameters in a group of HIV patients with and without lipoatrophy to examine whether lipoatrophy could explain the high prevalence of VDD and metabolic abnormalities.

[1]  T. Clemens,et al.  The osteoblast: An insulin target cell controlling glucose homeostasis , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  J. Fox,et al.  Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial. , 2011, AIDS research and human retroviruses.

[3]  D. Nolan,et al.  Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  F. Ibrahim,et al.  Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase , 2010, AIDS.

[5]  D. D. de Luis,et al.  Relation of phase angle tertiles with blood adipocytokines levels, insulin resistance and cardiovascular risk factors in obese women patients. , 2010, European review for medical and pharmacological sciences.

[6]  H. Bischoff-Ferrari,et al.  High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients , 2010, AIDS.

[7]  S. Chanprasertyothin,et al.  The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance , 2009, Endocrine.

[8]  K. Gyllensten,et al.  Regulation of Human Vitamin D3 25-Hydroxylases in Dermal Fibroblasts and Prostate Cancer LNCaP Cells , 2009, Molecular Pharmacology.

[9]  R. Monge-Rojas,et al.  Components of the Metabolic Syndrome among a Sample of Overweight and Obese Costa Rican Schoolchildren , 2009, Food and nutrition bulletin.

[10]  S. Khalifé,et al.  Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. , 2009, European journal of endocrinology.

[11]  S. Booth,et al.  Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. , 2009, Journal of NutriLife.

[12]  K. Arastéh,et al.  Efavirenz-induced osteomalacia. , 2009, AIDS.

[13]  S. Mallal,et al.  Longitudinal evaluation of cardiovascular disease-associated biomarkers in relation to abacavir therapy , 2008, AIDS.

[14]  F. Sweep,et al.  Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. , 2008, AIDS research and human retroviruses.

[15]  N. Wareham,et al.  Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance , 2008, Diabetes.

[16]  H. Wand,et al.  Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria , 2007, Diabetes Care.

[17]  P. Glendenning,et al.  Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays , 2006, Annals of clinical biochemistry.

[18]  M. Visser,et al.  Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. , 2005, The Journal of clinical endocrinology and metabolism.

[19]  C. Mantzoros,et al.  Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. , 2003, The Journal of clinical endocrinology and metabolism.

[20]  S. Epstein,et al.  Evidence for alteration of the vitamin D-endocrine system in obese subjects. , 1985, The Journal of clinical investigation.